Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Qingdao Xingsai Biotechnology

Request full access

A developer of single-cell analysis instruments and supporting reagents and consumables

Qingdao, ChinaFounded 2014Biotech & Life Sciences

About Qingdao Xingsai Biotechnology

Established in 2014 and headquartered in Qingdao, China, Qingdao Xingsai Biotechnology Co., Ltd. operates within the biotechnology and medical device sectors, specializing in single-cell analysis. The company's revenue model is centered on the development and sale of scientific instruments, associated software, and reagent consumables. Their offerings provide solutions for metabolic phenome-based single-cell imaging, sorting, sequencing, and culture.

The company's product portfolio is segmented into instruments, kits & chips, and software. Key instruments include the FlowRACS, a high-throughput flow Raman sorter; the CAST-R for clinical antimicrobial susceptibility testing; and the RACS-Seq for Raman-activated cell sorting and sequencing. Their software suite, comprising RamEX, RamDB, and RamLIS, supports the hardware. These products serve a diverse client base across precision medicine, human and environmental micro-ecology, and bioresource mining.

A significant figure in the company is co-founder Xu Jian, who also serves as the director of the Bioenergy Research Office and the Single Cell Center of the Qingdao Institute of Energy, Chinese Academy of Sciences. The company has secured strategic funding, including a round in April 2024, with investors such as Neovision Capital, Nanjing Gaoke, and Hengxu Capital backing its growth.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
21.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jan 2026 $14M $55M Zheshang Capital · Shandong Caijin Venture Capital ↗
EARLY VC✓Equity / VC Apr 2024 $0 — Kweichow Moutai ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Qingdao Xingsai Biotechnology website traffic

Latest recorded traffic for Qingdao Xingsai Biotechnology is 390 monthly website visits, down 67.5% over the last three months.

Latest monthly visits390 3-month web change-67.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Qingdao Xingsai Biotechnology in the Qingdao ecosystem

Live from Dealroom

The Qingdao Xingsai Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Neovision Capital

Series A5 investors entered at this stage

  • Hengxu Capital
  • Beiyang Haitang Fund
  • Kweichow Moutai
  • Zheshang Capital
  • Shandong Caijin Venture Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Qingdao HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Qingdao Xingsai Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Qingdao Xingsai Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.